The clinical implications of gemcitabine radiosensitization.
T H
TH
Doyle
F
F
Mornex
W G
WG
McKenna
D017209:Apoptosis / Q000528:radiation effects*; D020169:Caspases / Q000378:metabolism; D002470:Cell Survival / Q000528:radiation effects; D003037:Cobalt Radioisotopes; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D000093542:Gemcitabine
D003037:Cobalt Radioisotopes; D011838:Radiation-Sensitizing Agents; D003841:Deoxycytidine; D020169:Caspases; D000093542:Gemcitabine